electroCore (ECOR) Expected to Announce Quarterly Earnings on Wednesday

electroCore (NASDAQ:ECOR) will likely be issuing its Q4 2025 results before the market opens on Wednesday, March 11th. Analysts expect the company to announce earnings of ($0.35) per share for the quarter. Individuals may review the information on the company’s upcoming Q4 2025 earning report for the latest details on the call scheduled for Thursday, March 12, 2026 at 4:00 PM ET.

electroCore Trading Down 2.1%

ECOR stock opened at $7.61 on Wednesday. The firm has a 50-day moving average of $6.13 and a two-hundred day moving average of $5.44. electroCore has a 12 month low of $4.16 and a 12 month high of $15.68. The company has a market cap of $60.88 million, a price-to-earnings ratio of -4.45 and a beta of 0.48.

Institutional Trading of electroCore

A number of hedge funds and other institutional investors have recently modified their holdings of ECOR. NewEdge Advisors LLC lifted its position in electroCore by 857.9% in the first quarter. NewEdge Advisors LLC now owns 161,955 shares of the company’s stock valued at $1,083,000 after buying an additional 145,047 shares during the last quarter. DRW Securities LLC acquired a new stake in shares of electroCore during the fourth quarter valued at about $264,000. Jane Street Group LLC raised its stake in shares of electroCore by 114.4% in the 1st quarter. Jane Street Group LLC now owns 36,726 shares of the company’s stock valued at $246,000 after acquiring an additional 19,599 shares during the period. Cubist Systematic Strategies LLC purchased a new stake in shares of electroCore in the 1st quarter valued at approximately $153,000. Finally, Two Sigma Investments LP lifted its holdings in shares of electroCore by 20.8% in the 3rd quarter. Two Sigma Investments LP now owns 24,603 shares of the company’s stock worth $122,000 after acquiring an additional 4,231 shares during the last quarter. 26.74% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

ECOR has been the topic of a number of analyst reports. Brookline Capital Acquisition upgraded electroCore to a “strong-buy” rating in a research report on Tuesday, February 3rd. Zacks Research downgraded electroCore from a “hold” rating to a “strong sell” rating in a research note on Wednesday, January 28th. Wall Street Zen upgraded electroCore from a “sell” rating to a “hold” rating in a report on Saturday, November 8th. HC Wainwright lowered their price target on shares of electroCore from $25.00 to $18.00 and set a “buy” rating on the stock in a research report on Monday, January 26th. Finally, Weiss Ratings restated a “sell (d-)” rating on shares of electroCore in a research report on Monday, December 29th. One equities research analyst has rated the stock with a Strong Buy rating, two have given a Buy rating and two have given a Sell rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus price target of $22.00.

electroCore Company Profile

electroCore, Inc is a commercial-stage bioelectronic medicine company headquartered in Rockaway, New Jersey. The company specializes in the development and commercialization of non-invasive vagus nerve stimulation (nVNS) therapies designed to address a variety of neurological and inflammatory conditions. Established in 2006, electroCore has focused its efforts on translating neuromodulation science into a compact, patient-administered treatment device.

The company’s lead product, gammaCore®, is a handheld, battery-powered device that delivers nVNS through the skin to the cervical branch of the vagus nerve.